Jesse T Nelson1, Julia R Coleman2, Heather Carmichael3, Cyril Mauffrey4, David Rojas Vintimilla4, Jason M Samuels3, Angela Sauaia5, Ernest E Moore6. 1. Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois. 2. Department of Surgery, University of Colorado-Denver, Aurora, Colorado. Electronic address: julia.coleman@cuanschutz.edu. 3. Department of Surgery, University of Colorado-Denver, Aurora, Colorado. 4. Department of Orthopedics, Denver Health Medical Center, Denver, Colorado. 5. Department of Surgery, University of Colorado-Denver, Aurora, Colorado; Department of Health Systems, Management and Policy, University of Colorado-Denver, School of Public Health, Aurora, Colorado. 6. Department of Surgery, University of Colorado-Denver, Aurora, Colorado; Department of Surgery, Denver Health Medical Center, Denver, Colorado.
Abstract
BACKGROUND: Trauma patients with pelvic fractures have a high rate of venous thromboembolism (VTEs). The reason for this high rate is unknown. We hypothesize that fibrinolysis shutdown (SD) predicts VTE in patients with severe pelvic fracture. METHODS: Retrospective chart review of trauma patients who presented with pelvic fracture from 2007 to 2017 was performed. Inclusion criteria were injury severity score > 15, abdomen/pelvis abbreviated injury scale >/= 3, blunt mechanism, admission citrated rapid thrombelastography (TEG). Fibrinolytic phenotypes were defined by fibrinolysis on citrated rapid TEG as hyperfibrinolysis, physiologic lysis, and SD. Univariate analysis of TEG measurements and clinical outcomes, followed by multivariable logistic regression (MV) with stepwise selection, was performed. RESULTS: Overall, 210 patients were included. Most patients (59%) presented in fibrinolytic shutdown. VTE incidence was 11%. There were no significant differences in fibrinolytic phenotypes or other TEG measurements between those who developed VTE and those who did not. There was a higher rate of VTE in patients who underwent pelvic external fixation or resuscitative thoracotomy. On MV, pelvic fixation and resuscitative thoracotomy were independent predictors of VTE. CONCLUSIONS: In severely injured patients with pelvic fractures, there was a high rate of VTE and the majority presented in SD. However, we were unable to correlate initial SD with VTE. Ultimately, the high rate of VTE in this patient population supports the concept of implementing VTE chemoprophylaxis measures as soon as hemostasis is achieved.
BACKGROUND:Traumapatients with pelvic fractures have a high rate of venous thromboembolism (VTEs). The reason for this high rate is unknown. We hypothesize that fibrinolysis shutdown (SD) predicts VTE in patients with severe pelvic fracture. METHODS: Retrospective chart review of traumapatients who presented with pelvic fracture from 2007 to 2017 was performed. Inclusion criteria were injury severity score > 15, abdomen/pelvis abbreviated injury scale >/= 3, blunt mechanism, admission citrated rapid thrombelastography (TEG). Fibrinolytic phenotypes were defined by fibrinolysis on citrated rapid TEG as hyperfibrinolysis, physiologic lysis, and SD. Univariate analysis of TEG measurements and clinical outcomes, followed by multivariable logistic regression (MV) with stepwise selection, was performed. RESULTS: Overall, 210 patients were included. Most patients (59%) presented in fibrinolytic shutdown. VTE incidence was 11%. There were no significant differences in fibrinolytic phenotypes or other TEG measurements between those who developed VTE and those who did not. There was a higher rate of VTE in patients who underwent pelvic external fixation or resuscitative thoracotomy. On MV, pelvic fixation and resuscitative thoracotomy were independent predictors of VTE. CONCLUSIONS: In severely injured patients with pelvic fractures, there was a high rate of VTE and the majority presented in SD. However, we were unable to correlate initial SD with VTE. Ultimately, the high rate of VTE in this patient population supports the concept of implementing VTE chemoprophylaxis measures as soon as hemostasis is achieved.
Authors: Benjamin Young; Drayton Daily; Clarence Kee; Kevin Perry; Massimo Max Morandi; R Shane Barton; Giovanni F Solitro Journal: Eur J Orthop Surg Traumatol Date: 2020-05-01
Authors: Michael J Gouzoulis; Peter Y Joo; Alexander J Kammien; William M McLaughlin; Brad Yoo; Jonathan N Grauer Journal: PLoS One Date: 2022-10-20 Impact factor: 3.752
Authors: Zachary A Matthay; Zane J Hellmann; Brenda Nunez-Garcia; Alexander T Fields; Joseph Cuschieri; Matthew D Neal; Jeffrey S Berger; Elliot Luttrell-Williams; M Margaret Knudson; Mitchell J Cohen; Rachael A Callcut; Lucy Z Kornblith Journal: J Trauma Acute Care Surg Date: 2022-04-21 Impact factor: 3.697
Authors: Christiaan N Mamczak; Jacob Speybroeck; John E Stillson; Joseph Dynako; Andres Piscoya; Ethan E Peck; Michael Aboukhaled; Emily Cancel; Michael McDonald; Diego Garcia; John Lovejoy; Stephanie Lubin; Robert Stanton; Matthew E Kutcher Journal: J Clin Med Date: 2022-07-12 Impact factor: 4.964